Opaleye Management Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,800,400
-21.6%
1,890,000
+387.7%
5.14%
+95.2%
Q4 2020$20,158,000
+93.2%
387,500
-0.6%
2.63%
+29.0%
Q3 2020$10,436,000
+17.3%
390,000
-14.6%
2.04%
+13.6%
Q2 2020$8,895,000
+83.4%
456,600
-7.4%
1.80%
+39.8%
Q1 2020$4,851,000
-24.6%
493,000
-14.9%
1.28%
+1.8%
Q4 2019$6,434,000
+87.1%
579,651
-5.4%
1.26%
+1.4%
Q3 2019$3,439,000
-65.4%
612,500
-46.7%
1.24%
-59.0%
Q2 2019$9,948,000
-9.4%
1,150,000
-15.8%
3.03%
-0.3%
Q1 2019$10,983,000
+387.1%
1,366,062
+148.4%
3.04%
+261.6%
Q4 2018$2,255,000
+15.1%
550,000
+57.1%
0.84%
+68.5%
Q3 2018$1,960,000
-76.1%
350,000
-44.0%
0.50%
-76.5%
Q2 2018$8,218,000
+111.1%
625,000
+127.9%
2.13%
+91.1%
Q1 2018$3,893,000
+266.9%
274,200
+56.7%
1.11%
+57.0%
Q2 2016$1,061,000
-70.0%
175,000
-57.8%
0.71%
-67.8%
Q1 2016$3,536,000
-1.2%
415,000
+38.3%
2.20%
+47.4%
Q4 2015$3,579,000
+36.6%
300,000
+15.4%
1.50%
+16.0%
Q3 2015$2,621,000260,0001.29%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders